InStride Health Announces Leadership Team Changes to Enhance Anxiety and OCD Treatment

BOSTON, November 4, 2025 — Leads & Copy — InStride Health has announced changes to its leadership team, including the addition of Jeremy Keim as Senior Vice President of Payor Growth & Strategy and the promotions of Parker Phillips to Chief Technology Officer and Allison Montick, LCSW, to Chief Clinical Operations Officer. These leaders will work together to expand access to evidence-based anxiety and obsessive-compulsive disorder (OCD) care.

Keim, with over 22 years of healthcare experience, will lead InStride’s payor strategy and expansion efforts. He previously worked at Aetna and Optum.

Phillips, formerly Senior Vice President of Technology, will advance the use of AI and data. He has been with InStride since its beginning.

Montick, promoted from Senior Vice President of Clinical Operations, will strengthen InStride’s clinical delivery systems. Before joining InStride in early 2024, Montick oversaw clinical delivery and operations for a nationwide network of more than 2,500 therapists and coaches and helped guide the company through its successful acquisition by Optum.

Matt Miller
V2 Communications
Instride@v2comms.com

Source: InStride Health

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.